A PYMNTS Company

Chile: FNE accuses Biosano and Sanderson labs of bid rigging

By  |  August 9, 2016

Chile’s National Economic Prosecutor (FNE) has presented its counterpart, the Tribunal for the Defense of Free Competition (TDLC) with charges against local drug-makers Laboratorio Biosano, Fresenius Kabi Chile and its affiliate Laboratorio Sanderson. Authorities have accused the companies of forming a decade-long arrangement to rig government contract bidding. The labs are the country’s only makers of medical ampoules for generic medication.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The FNE charges accuse the labs of rigging bids for supplying the national health system by defining beforehand which of the two would be the winner of each contest. The cartel would coordinate reference prices and adjust their offers to ensure the ‘right’ company would win a specific contract.

    The FNE has asked for a fine of 18 thousand UTA units for Sanderson and 2 thousand UTA units for Biosano, bringing the total to around $17 million USD. Biosano was able to avoid sanctions due to its cooperation under Chile’s leniency program for antitrust violators.

    Full Content: La Tercera

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.